A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

NCT04277910 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: MT2004
DRUG: Placebo

Sponsor

Xi'an Biocare Pharma Ltd.